Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

Janelle M Guirguis-Blake; Corinne V Evans; Megan Rushkin

doi:10.1001/jama.2018.17847

Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

JAMA. 2019 Jan 29;321(4):404-406. doi: 10.1001/jama.2018.17847.

Authors

Janelle M Guirguis-Blake¹, Corinne V Evans¹, Megan Rushkin¹

Affiliation

¹ Kaiser Permanente Research Affiliates Evidence-based Practice Center, Kaiser Permanente Center for Health Research, Portland, Oregon.

Abstract

This systematic review to support the 2019 US Preventive Services Task Force Reaffirmation Recommendation Statement on ocular prophylaxis for gonococcal ophthalmia neonatorum summarizes published evidence on the benefits and harms of ocular topical medication to prevent gonococcal conjunctival infection in newborns.

Publication types

Research Support, U.S. Gov't, P.H.S.
Systematic Review

MeSH terms

Administration, Topical
Anti-Bacterial Agents / adverse effects
Anti-Bacterial Agents / therapeutic use*
Erythromycin / therapeutic use
Humans
Infant, Newborn
Ointments
Ophthalmia Neonatorum / prevention & control*
Practice Guidelines as Topic

Substances

Anti-Bacterial Agents
Ointments
Erythromycin